A study evaluating early PSA response to Enzalutamide treatment for Japanese patients with metastatic castration-resistant prostate cancer.
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2017
At a glance
- Drugs Enzalutamide (Primary) ; Docetaxel
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- 27 Oct 2017 New trial record